Oral Cancer Treatment Costs in Greece and the Effect of Advanced Disease

BMC Public Health - United Kingdom
doi 10.1186/1471-2458-2-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapeutic Effect and Adverse Reaction of Sorafenib in the Treatment of Advanced Renal Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Treatment of the Advanced Disease

BMJ
1970English

PS1-26: Treatment Costs of Advanced Cancer: Variation in Costs for Stage IV vs. Recurrent Breast, Colorectal, Lung, and Prostate Cancers

Clinical Medicine and Research
MedicineHome CareCommunity
2013English

Diagnosis and Treatment of Oral Disease

BMJ
1937English

Lung Cancer Treatment Costs, Including Patient Responsibility, by Disease Stage and Treatment Modality, 1992 to 2003

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

The Costs and Benefits of Intensive Treatment for Cardiovascular Disease

1998English

Budget Impact of Alectinib in the Treatment of Naïve Anaplastic Lymphoma Kinase-Positive (ALK+) Advanced Non-Small Cell Lung Cancer (NSCLC) in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Evolution of Oral Health in Oral Cancer Patients With and Without Dental Treatment in Place: Before, During and After Cancer Treatment

Journal of Clinical and Experimental Dentistry
Dentistry
2018English

Oral Vinorelbine: A Feasible and Safe Partner for Radiotherapy in the Treatment of Locally Advanced Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy